Evidence map›Paper›PMID 27788162›Full record

ArticlePloS one2016

Mining, Validation, and Clinical Significance of Colorectal Cancer (CRC)-Associated lncRNAs.

Xiangwei Sun, Yingying Hu, Liang Zhang, Changyuan Hu, Gangqiang Guo, Chenchen Mao, Jianfeng Xu, Sisi Ye, Guanli Huang, Xiangyang Xue and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Non-coding RNA: It's Not Junk.Digestive diseases and sciences · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xiangwei SunDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Yingying HuDepartment of Obstetrics and Gynecology, Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Liang ZhangDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Changyuan HuDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Gangqiang GuoDepartment of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, China.
Chenchen MaoDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Jianfeng XuDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Sisi YeDepartment of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, China.
Guanli HuangDepartment of Surgical Oncology, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Xiangyang XueDepartment of Microbiology and Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, Wenzhou Medical University, Wenzhou, China.
Aizhen GuoDepartment of Internal Medicine, Yangpu Hosptial, Tongji University School of Medicine, Shanghai, China.
Xian ShenDepartment of General Surgery, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Wenzhou Medical University · CNFirst Affiliated Hospital of Wenzhou Medical University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is one of the deadliest tumours, but its pathogenesis remains unclear. The involvement of differentially expressed long non-coding RNAs (lncRNAs) in CRC tumorigenesis makes them suitable tumour biomarkers. METHODS/

findingsHere, we screened 150 cases of CRC and 85 cases of paracancerous tissues in the GEO database for differentially expressed lncRNAs. The levels of lncRNA candidates in 84 CRC and paracancerous tissue samples were validated by qRT-PCR and their clinical significance was analyzed. We identified 15 lncRNAs with differential expression in CRC tumours; among them, AK098081 was significantly up-regulated, whereas AK025209, BC040303, BC037331, AK026659, and CR749831 were down-regulated in CRC. In a receiver operating characteristic curve analysis, the area under the curve for the six lncRNAs was 0.914. High expression of AK098081 and low expression of BC040303, CR749831, and BC037331 indicated poor CRC differentiation. CRC patients with lymph node metastasis had lower expression of BC037331. In addition, the group with high AK098081 expression presented significantly lower overall survival and disease-free survival rates than the low-expression group, confirming AK098081 as an independent risk factor for CRC patients. CONCLUSION/SIGNIFICANCE: In conclusion, we have identified multiple CRC-associated lncRNAs from microarray expression profiles that can serve as novel biomarkers for the diagnosis and prognosis of CRC.

Indexed as

Colorectal NeoplasmsData MiningFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic MarkersHumansKaplan-Meier EstimateMaleMiddle AgedProportional Hazards ModelsReal-Time Polymerase Chain ReactionRNA, Long NoncodingTranscriptomeGenetic MarkersRNA, Long Noncoding

Identifiers

PMID27788162
PMCPMC5082825
OpenAlexW2541494137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.